Related Experiment Video
Updated: May 17, 2026
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Diabetes in Kyrgyzstan: changes between 2002 and 2009
David Beran1, Aida Abdraimova, Baktygul Akkazieva
1Division of International and Humanitarian Medicine, Faculty of Medicine, University of Geneva, Rue Gabrielle-Perret-Gentil 6, CH-1211, Geneva 14, Switzerland. david.beran@unige.ch
The International Journal of Health Planning and Management
|November 6, 2012
Summary
Health system reforms in Kyrgyzstan improved diabetes care access and insulin availability since 2006. Despite procurement inefficiencies, a new law empowers diabetes associations, fostering optimism for future care enhancements.
Area of Science:
- Public Health
- Health Services Research
- Central Asian Healthcare Systems
Background:
- Kyrgyzstan's health system reforms initially prioritized structural changes.
- Focus shifted to care delivery and user experience in 2006.
- A 2002 study provided a baseline for diabetes management assessment.
Purpose of the Study:
- To evaluate diabetes management in Kyrgyzstan in 2009.
- To assess changes since the 2002 baseline study.
- To analyze insulin access using the Rapid Assessment Protocol for Insulin Access.
Main Methods:
- Utilized the Rapid Assessment Protocol for Insulin Access (2009).
- Compared 2009 findings with a 2002 baseline study.
- Evaluated the government's medicine procurement system.
Main Results:
- Improved access to care via Family Medical Centres and endocrinologist deployment.
- Enhanced access to insulin and related medicines.
- Identified significant inefficiencies in the government's procurement system, yielding poor value for money.
Conclusions:
- Health system reforms have positively impacted diabetes care access.
- The new diabetes law empowers patient associations, contributing to care improvements.
- Continued implementation of the diabetes law is expected to further enhance care quality.
Related Concept Videos
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...